Literature DB >> 10933073

Applications of magnetic resonance in model systems: tumor biology and physiology.

R J Gillies1, Z M Bhujwalla, J Evelhoch, M Garwood, M Neeman, S P Robinson, C H Sotak, B Van Der Sanden.   

Abstract

A solid tumor presents a unique challenge as a system in which the dynamics of the relationship between vascularization, the physiological environment and metabolism are continually changing with growth and following treatment. Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) studies have demonstrated quantifiable linkages between the physiological environment, angiogenesis, vascularization and metabolism of tumors. The dynamics between these parameters continually change with tumor aggressiveness, tumor growth and during therapy and each of these can be monitored longitudinally, quantitatively and non-invasively with MRI and MRS. An important aspect of MRI and MRS studies is that techniques and findings are easily translated between systems. Hence, pre-clinical studies using cultured cells or experimental animals have a high connectivity to potential clinical utility. In the following review, leaders in the field of MR studies of basic tumor physiology using pre-clinical models have contributed individual sections according to their expertise and outlook. The following review is a cogent and timely overview of the current capabilities and state-of-the-art of MRI and MRS as applied to experimental cancers. A companion review deals with the application of MR methods to anticancer therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933073      PMCID: PMC1531870          DOI: 10.1038/sj.neo.7900076

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  105 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor.

Authors:  C D Pham; T P Roberts; N van Bruggen; O Melnyk; J Mann; N Ferrara; R L Cohen; R C Brasch
Journal:  Cancer Invest       Date:  1998       Impact factor: 2.176

3.  Correlation of high lactate levels in head and neck tumors with incidence of metastasis.

Authors:  S Walenta; A Salameh; H Lyng; J F Evensen; M Mitze; E K Rofstad; W Mueller-Klieser
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

4.  An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells.

Authors:  A Jang; R P Hill
Journal:  Clin Exp Metastasis       Date:  1997-09       Impact factor: 5.150

5.  Metabolite specific proton magnetic resonance imaging.

Authors:  R E Hurd; D M Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

7.  Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.

Authors:  J H Kaanders; L A Pop; H A Marres; J Liefers; F J van den Hoogen; W A van Daal; A J van der Kogel
Journal:  Radiother Oncol       Date:  1998-08       Impact factor: 6.280

8.  Metabolic flux determination in C6 glioma cells using carbon-13 distribution upon [1-13C]glucose incubation.

Authors:  J C Portais; R Schuster; M Merle; P Canioni
Journal:  Eur J Biochem       Date:  1993-10-01

9.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

Authors:  L E Benjamin; D Golijanin; A Itin; D Pode; E Keshet
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.

Authors:  P J Hoskin; M I Saunders; H Phillips; H Cladd; M E Powell; K Goodchild; M R Stratford; A Rojas
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  32 in total

1.  Noninvasive real-time imaging of apoptosis.

Authors:  Bharathi Laxman; Daniel E Hall; Mahaveer Swaroop Bhojani; Daniel A Hamstra; Thomas L Chenevert; Brian D Ross; Alnawaz Rehemtulla
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-10       Impact factor: 11.205

Review 2.  Applications of magnetic resonance in model systems: cancer therapeutics.

Authors:  J L Evelhoch; R J Gillies; G S Karczmar; J A Koutcher; R J Maxwell; O Nalcioglu; N Raghunand; S M Ronen; B D Ross; H M Swartz
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

Review 3.  Novel agents for chemoprevention, screening methods, and sampling issues.

Authors:  Mary Jo Fackler; Ella Evron; Seema A Khan; Saraswati Sukumar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

Review 4.  Preclinical development of molecular-targeted agents for cancer.

Authors:  Alberto Ocana; Atanasio Pandiella; Lillian L Siu; Ian F Tannock
Journal:  Nat Rev Clin Oncol       Date:  2010-12-07       Impact factor: 66.675

5.  Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging.

Authors:  Simon P Robinson; Tammy L Kalber; Franklyn A Howe; Dominick J O McIntyre; John R Griffiths; David C Blakey; Lynsey Whittaker; Anderson J Ryan; John C Waterton
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

6.  Measurement of kinetic parameters in skeletal muscle by magnetic resonance imaging with an intravascular agent.

Authors:  Anthony Z Faranesh; Dara L Kraitchman; Elliot R McVeigh
Journal:  Magn Reson Med       Date:  2006-05       Impact factor: 4.668

7.  Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.

Authors:  Bénédicte F Jordan; Matthew Runquist; Natarajan Raghunand; Amanda Baker; Ryan Williams; Lynn Kirkpatrick; Garth Powis; Robert J Gillies
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

Review 8.  Heart failure with preserved ejection fraction: the missing pieces in diagnostic imaging.

Authors:  Sadi Loai; Hai-Ling Margaret Cheng
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

9.  Vascular Reactivity Maps in Patients with Gliomas Using Breath-Holding BOLD fMRI.

Authors:  Amir Iranmahboob; Kyung K Peck; Nicole P Brennan; Sasan Karimi; Ryan Fisicaro; Bob Hou; Andrei I Holodny
Journal:  J Neuroimaging       Date:  2016 Mar-Apr       Impact factor: 2.486

10.  Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling study.

Authors:  J Klawitter; N Anderson; J Klawitter; U Christians; D Leibfritz; S G Eckhardt; N J Serkova
Journal:  Br J Cancer       Date:  2009-03-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.